AMNIO2X Trademark

Trademark Overview

On Saturday, November 5, 2016, a trademark application was filed for AMNIO2X with the United States Patent and Trademark Office. The USPTO has given the AMNIO2X trademark a serial number of 87227557. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Tuesday, May 28, 2024. The AMNIO2X trademark is filed in the Pharmaceutical Products category with the following description:

Implantable tissue derived from human amniotic fluid cells
amnio2x

General Information

Serial Number87227557
Word MarkAMNIO2X
Filing DateSaturday, November 5, 2016
Status710 - CANCELLED - SECTION 8
Status DateTuesday, May 28, 2024
Registration Number5333161
Registration DateTuesday, November 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2017

Trademark Statements

Goods and ServicesImplantable tissue derived from human amniotic fluid cells

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateTuesday, May 28, 2024
Primary Code005
First Use Anywhere DateTuesday, November 1, 2016
First Use In Commerce DateTuesday, November 1, 2016

Trademark Owner History

Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressMiami Beach, FL 33139
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressMiami Beach, FL 33139
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMiami Beach, FL 33139

Trademark Events

Event DateEvent Description
Wednesday, November 9, 2016NEW APPLICATION ENTERED
Monday, March 20, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 13, 2017ASSIGNED TO EXAMINER
Monday, February 20, 2017NON-FINAL ACTION WRITTEN
Monday, February 20, 2017NON-FINAL ACTION E-MAILED
Monday, February 20, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 22, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 22, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 23, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 20, 2017NON-FINAL ACTION E-MAILED
Wednesday, August 9, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, December 12, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 20, 2017NON-FINAL ACTION WRITTEN
Wednesday, June 14, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 20, 2017ASSIGNED TO LIE
Friday, July 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, July 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 29, 2017PUBLISHED FOR OPPOSITION
Friday, March 20, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 14, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 28, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, December 12, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 20, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

amnio amniotic fluid cells human from tissue derived implantable